These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37248964)

  • 1. Compound-42 alleviates acute kidney injury by targeting RIPK3-mediated necroptosis.
    He XY; Wang F; Suo XG; Gu MZ; Wang JN; Xu CH; Dong YH; He Y; Zhang Y; Ji ML; Chen Y; Zhang MM; Fan YG; Wen JG; Jin J; Wang J; Li J; Zhuang CL; Liu MM; Meng XM
    Br J Pharmacol; 2023 Oct; 180(20):2641-2660. PubMed ID: 37248964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RIPK1 inhibitor Cpd-71 attenuates renal dysfunction in cisplatin-treated mice via attenuating necroptosis, inflammation and oxidative stress.
    Wang JN; Liu MM; Wang F; Wei B; Yang Q; Cai YT; Chen X; Liu XQ; Jiang L; Li C; Hu XW; Yu JT; Ma TT; Jin J; Wu YG; Li J; Meng XM
    Clin Sci (Lond); 2019 Jul; 133(14):1609-1627. PubMed ID: 31315969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RIPK3 inhibitor-AZD5423 alleviates acute kidney injury by inhibiting necroptosis and inflammation.
    Xu CH; Wang JN; Suo XG; Ji ML; He XY; Chen X; Zhu S; He Y; Xie SS; Li C; Dong ZH; Chen Y; Ni WJ; Feng XW; Liu MM; Jin J; Li Z; Meng XM
    Int Immunopharmacol; 2022 Nov; 112():109262. PubMed ID: 36166972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of a chalcone derivative as potent necroptosis inhibitor for the treatment of acute kidney injury.
    Li C; Chen QY; He Y; Liu YH; Meng XM; Liu MM
    Clin Exp Pharmacol Physiol; 2022 Aug; 49(8):824-835. PubMed ID: 35579574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Bcr-Abl inhibitor GNF-7 inhibits necroptosis and ameliorates acute kidney injury by targeting RIPK1 and RIPK3 kinases.
    Qin X; Hu L; Shi SN; Chen X; Zhuang C; Zhang W; Jitkaew S; Pang X; Yu J; Tan YX; Wang HY; Cai Z
    Biochem Pharmacol; 2020 Jul; 177():113947. PubMed ID: 32247850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stratifin promotes renal dysfunction in ischemic and nephrotoxic AKI mouse models via enhancing RIPK3-mediated necroptosis.
    Wang F; Wang JN; He XY; Suo XG; Li C; Ni WJ; Cai YT; He Y; Fang XY; Dong YH; Xing T; Yang YR; Zhang F; Zhong X; Zang HM; Liu MM; Li J; Meng XM; Jin J
    Acta Pharmacol Sin; 2022 Feb; 43(2):330-341. PubMed ID: 33833407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 7-Hydroxycoumarin protects against cisplatin-induced acute kidney injury by inhibiting necroptosis and promoting Sox9-mediated tubular epithelial cell proliferation.
    Wu WF; Wang JN; Li Z; Wei B; Jin J; Gao L; Li HD; Li J; Chen HY; Meng XM
    Phytomedicine; 2020 Apr; 69():153202. PubMed ID: 32169782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RIPK3 deficiency or catalytically inactive RIPK1 provides greater benefit than MLKL deficiency in mouse models of inflammation and tissue injury.
    Newton K; Dugger DL; Maltzman A; Greve JM; Hedehus M; Martin-McNulty B; Carano RA; Cao TC; van Bruggen N; Bernstein L; Lee WP; Wu X; DeVoss J; Zhang J; Jeet S; Peng I; McKenzie BS; Roose-Girma M; Caplazi P; Diehl L; Webster JD; Vucic D
    Cell Death Differ; 2016 Sep; 23(9):1565-76. PubMed ID: 27177019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cpd-42 protects against calcium oxalate nephrocalcinosis-induced renal injury and inflammation by targeting RIPK3-mediated necroptosis.
    Hou B; Liu M; Chen Y; Ni W; Suo X; Xu Y; He Q; Meng X; Hao Z
    Front Pharmacol; 2022; 13():1041117. PubMed ID: 36408256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RIPK3-MLKL-mediated necroinflammation contributes to AKI progression to CKD.
    Chen H; Fang Y; Wu J; Chen H; Zou Z; Zhang X; Shao J; Xu Y
    Cell Death Dis; 2018 Aug; 9(9):878. PubMed ID: 30158627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Necroptosis in 3-chloro-1, 2-propanediol (3-MCPD)-dipalmitate-induced acute kidney injury in vivo and its repression by miR-223-3p.
    Huang G; Xue J; Sun X; Wang J; Yu LL
    Toxicology; 2018 Aug; 406-407():33-43. PubMed ID: 29860048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cytosolic heat shock protein 90 and co-chaperone p23 complex activates RIPK3/MLKL during necroptosis of endothelial cells in acute respiratory distress syndrome.
    Yu X; Mao M; Liu X; Shen T; Li T; Yu H; Zhang J; Chen X; Zhao X; Zhu D
    J Mol Med (Berl); 2020 Apr; 98(4):569-583. PubMed ID: 32072232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dimethyl fumarate inhibits necroptosis and alleviates systemic inflammatory response syndrome by blocking the RIPK1-RIPK3-MLKL axis.
    Shi FL; Yuan LS; Wong TS; Li Q; Li YP; Xu R; You YP; Yuan T; Zhang HR; Shi ZJ; Zha QB; Hu B; He XH; Ouyang DY
    Pharmacol Res; 2023 Mar; 189():106697. PubMed ID: 36796462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligustroflavone reduces necroptosis in rat brain after ischemic stroke through targeting RIPK1/RIPK3/MLKL pathway.
    Zhang YY; Liu WN; Li YQ; Zhang XJ; Yang J; Luo XJ; Peng J
    Naunyn Schmiedebergs Arch Pharmacol; 2019 Sep; 392(9):1085-1095. PubMed ID: 31055628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salt-inducible kinases inhibitor HG-9-91-01 targets RIPK3 kinase activity to alleviate necroptosis-mediated inflammatory injury.
    Huang D; Chen P; Huang G; Sun H; Luo X; He C; Chen F; Wang Y; Zeng C; Su L; Zeng X; Lu J; Li S; Huang D; Gao H; Cao M
    Cell Death Dis; 2022 Feb; 13(2):188. PubMed ID: 35217652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenytoin inhibits necroptosis.
    von Mässenhausen A; Tonnus W; Himmerkus N; Parmentier S; Saleh D; Rodriguez D; Ousingsawat J; Ang RL; Weinberg JM; Sanz AB; Ortiz A; Zierleyn A; Becker JU; Baratte B; Desban N; Bach S; Schiessl IM; Nogusa S; Balachandran S; Anders HJ; Ting AT; Bleich M; Degterev A; Kunzelmann K; Bornstein SR; Green DR; Hugo C; Linkermann A
    Cell Death Dis; 2018 Mar; 9(3):359. PubMed ID: 29500402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wogonin protects against cisplatin-induced acute kidney injury by targeting RIPK1-mediated necroptosis.
    Meng XM; Li HD; Wu WF; Ming-Kuen Tang P; Ren GL; Gao L; Li XF; Yang Y; Xu T; Ma TT; Li Z; Huang C; Zhang L; Lv XW; Li J
    Lab Invest; 2018 Jan; 98(1):79-94. PubMed ID: 29200200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of RIPK3-regulated cell death pathways and necroptosis in the pathogenesis of cardiac ischaemia-reperfusion injury.
    Ying L; Benjanuwattra J; Chattipakorn SC; Chattipakorn N
    Acta Physiol (Oxf); 2021 Feb; 231(2):e13541. PubMed ID: 32687661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gentamicin-Induced Acute Kidney Injury in an Animal Model Involves Programmed Necrosis of the Collecting Duct.
    Huang H; Jin WW; Huang M; Ji H; Capen DE; Xia Y; Yuan J; Păunescu TG; Lu HAJ
    J Am Soc Nephrol; 2020 Sep; 31(9):2097-2115. PubMed ID: 32641397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Z-DNA/RNA Binding Protein 1 Senses Mitochondrial DNA to Induce Receptor-Interacting Protein Kinase-3/Mixed Lineage Kinase Domain-Like-Driven Necroptosis in Developmental Sevoflurane Neurotoxicity.
    Wang WY; Yi WQ; Liu YS; Hu QY; Qian SJ; Liu JT; Mao H; Cai F; Yang HL
    Neuroscience; 2022 Dec; 507():99-111. PubMed ID: 36370933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.